Tulane virus (TV), the prototype of the Recovirus genus in the calicivirus family, was isolated from the stools of rhesus monkeys and can be cultivated in vitro in monkey kidney cells. TV is genetically closely related to the genus Norovirus and recognizes the histo-blood group antigens (HBGAs), similarly to human noroviruses (NoVs), making it a valuable surrogate for human NoVs. However, the precise structures of HBGAs recognized by TV remain elusive. In this study, we performed binding and blocking experiments on TV with extended HBGA types and showed that, while TV binds all four types (types 1 to 4) of the B antigens, it recognizes only the A type 3 antigen among four types of A antigens tested. The requirements for HBGAs in TV replication were demonstrated by blocking of TV replication in cell culture using the A type 3/4 and B saliva samples. Similar results were also observed in oligosaccharide-based blocking assays. Importantly, the previously reported, unexplained increase in TV replication by oligosaccharide in cell-based blocking assays has been clarified, which will facilitate the application of TV as a surrogate for human NoVs.
N oroviruses (NoVs), an important cause of nonbacterial acute gastroenteritis in humans, constitute the genus Norovirus of the calicivirus (CV) family. Other genera include Sapovirus, which also causes acute gastroenteritis in humans, Lagovirus, Vesivirus, Nebovirus, and the recently proposed genera Recovirus and Valovirus, which cause a wide variety of diseases in different animal species (1) (2) (3) . NoVs are further divided into over 30 genotypes classified into five genogroups; two of these (GI and GII) cause major epidemics of acute gastroenteritis in humans, while the remaining three (GIII to GV) mainly infect animals. Both GI and GII human NoVs recognize the human histo-blood group antigens (HBGAs) in a strain-specific manner as potential receptors or attachment factors (4) (5) (6) (7) , and a number of patterns of binding to different ABO, secretor, and Lewis antigens have been described (8) . Human NoVs are difficult to study due to the lack of an in vitro culture method and animal models (9) .
Tulane virus (TV) is the prototype of the genus Recovirus and was originally isolated from the stools of rhesus monkeys (10) . The TV can be cultivated in monkey kidney-derived cell lines, including LLC MK-2, Vero, and MA104. Recoviruses are genetically closest to the NoVs among the known genera in the calicivirus family (10) . A cryo-electron microscopy (cryo-EM) study showed that the TV capsid exhibits a typical icosahedral symmetry with unique conformational flexibility among C/C dimers of the protruding (P) domain compared with the A/B dimers of the TV capsid (11) . A challenge of rhesus monkeys with in vitro-cultivated TV resulted in intestinal infection with mild gastroenteritis, indicating that TV is an enteric pathogen (12) . Because the TV also recognizes the HBGAs like NoVs (13) , it has been used as a surrogate for human NoVs (14) (15) (16) (17) (18) .
HBGAs are complex carbohydrates distributed abundantly on mucosal epithelia of the respiratory, genitourinary, and digestive tracts and on the surfaces of red blood cells. These antigens are synthesized from various disaccharide precursors through sequential addition of monosaccharides catalyzed by specific glycosyltransferases that are encoded by three major HBGA gene families, including the ABO, secretor (H), and Lewis families.
Depending on the oligosaccharide residue and their linkages of the disaccharide precursors, HBGAs can be divided into six types (19) (19) . The structures of type 1 to 4 antigens that were studied here are shown in Fig. 1 . The H antigens are produced by the addition of a fucose in an ␣(1¡2) linkage to the ␤-galactose of the six different core chains. Both the A and B antigens are produced from the six types of H antigens by the addition of an N-acetylgalactosamine (A) or a galactose (B) in an ␣(1¡3) linkage to the terminal ␤-galactose. All six types of ABH antigens can be found on erythrocyte and tissue surfaces; of these six, types 1 to 4 are considered the most important (19) , and procedures to synthesize these glycans in vitro are available (20, 21) .
The binding of HBGAs by TV has been demonstrated by various binding and blocking assays; however, the precise structures of HBGAs responsible for TV binding remain unclear. A recent study showed that TV recognizes both type A and B saliva with variations among saliva samples in each type (13) .We also observed differences of TV binding to type B versus type A saliva, in which all type B saliva samples but only a subset of type A saliva samples were reactive to TV. These results indicate that further study to define the binding patterns of TV to human HBGAs is necessary. In addition, unexplainable results regarding the role of HBGAs in TV replication were reported: while significant reduction of TV replication in cell cultures was observed following treatments of the TV with type A and B saliva samples, treatments with bovine serum albumin (BSA)-conjugated A and B oligosaccharides increased TV titers (13) . Thus, our understanding of the roles of HBGAs in TV replication and host range remains limited.
In this study, we performed further binding and blocking experiments using reagents specific to different types of the ABH antigens to clarify these discrepancies. We demonstrated that the TV bound all four tested types (types 1 to 4) of the B antigens, consistent with the results of TV binding of all types B and AB HBGAs in the saliva-binding assays. However, TV bound only the A type 3 antigen among four types (types 1 to 4) of A oligosaccharide conjugates tested, suggesting that the lack of binding or weak binding of type A saliva samples to TV may be due to a lack of expression or low expression of the A type 3 antigens in these saliva. Accordingly, we showed that the blocking activities of saliva samples on TV replication in cell culture correlated with the binding signals by a monoclonal antibody (MAb) recognizing the A type 3/4 antigens. Finally, we found the reason for the previously described increase of TV replication by BSA-conjugated HBGA oligosaccharides and demonstrated the expected inhibition by these oligosaccharides. Together, our new data support the notion that TV recognizes HBGAs as attachment factors and that such recognition is required for TV infection and replication.
MATERIALS AND METHODS
Virus, MAbs, and synthetic oligosaccharides. Plaque-purified, low-passage-number TV stock was used for the plaque assay; the H type 3/4-specific MAb MBr1 (to globo-H) was purchased from Enzo Life Sciences, Inc. (Farmingdale, NY), and A type 3/4-specific MAb HE-10 was purchased from Sigma-Aldrich (St. Louis, MO). Polyacrylamide (PAA)-conjugated type A and B trisaccharides of approximately 30 kDa containing 20 mol% carbohydrate were purchased from GlycoTech Corporation, Rockville, MD; bovine serum albumin (BSA)-conjugated type A and B trisaccharides with 20 to 25 carbohydrate chains attached per BSA molecule were purchased from Glycorex AB (Lund Sweden). The H type 1 to 4, A type 1 to 4, and B type 1 to 4 BSA conjugates were prepared as described previously (22) , using antigens synthesized as reported previously (20, 21) . Briefly, the antigens were synthesized with an alkene at the reducing end that was converted to the corresponding amine salt using a photochemically induced thiol-ene reaction with cysteamine. The amine was then coupled with di-p-nitrophenyl adipate to generate an activated ester derivative (23) . These activated derivatives were reacted (22) with bovine serum albumin to give the neoglycoconjugates used the analyses. The structures of these different antigens are shown in Fig. 1 ; antigen loadings on BSA ranged from 11 to 16, as determined by matrix-assisted laser desorption ionization (MALDI) mass spectrometry.
Purification of TV and preparation of TV specific antibodies. Rhesus monkey kidney LLC-MK2 cells (ATCC, Manassas, VA) were cultured in rolling bottles with medium 199 (Mediatech, Manassas, VA) supplemented with 10% fetal bovine serum (FBS), 200 U/ml penicillin, and 200 g/ml streptomycin. Cells with 80 to 90% confluence were inoculated with 10 ml (multiplicity of infection [MOI] ϭ 0.4)) of TV inoculum for 1 h. were coupled to BSA through the reducing end. Gal, galactose; GalNAc, N-acetylgalactosamine; GlcNAc, N-acetylglucosamine; Fuc, fucose. Symbolic nomenclature used is that developed by the Consortium for Functional Glycomics.
Then the inoculum was removed, and 50 ml medium without FBS was added and cultured for 72 h. A total of 600 ml of TV-infected LLC-MK2 cell culture medium was concentrated in a dialysis tube against polyethylene glycol (PEG) 8000. Then the sample was adjusted for density (refractive index of 1.365) with cesium chloride and centrifuged at 288,000 ϫ g (41,000 rpm, SW41Ti rotor; Beckman) for 40 h. The gradient fractions were collected by bottom puncture. TV virions in the fractions were identified and quantified by transmission electron microscopy (TEM), SDS-PAGE, Western blotting, and reverse transcription-PCR (RT-PCR). The CsCl-purified TVs were used for generation of antibody against TV.
For generation of an anti-TV antibody, female BALB/c mice (n ϭ 4; Harlan-Sprague-Dawley, Indianapolis, IN) at 3 to 4 weeks of age were immunized with purified TV three times through intraperitoneal injection with adjuvant in 2-week intervals. Blood was collected by retro-orbital capillary plexus puncture before each immunization and 4 weeks after the final immunization. Sera were processed from blood via a standard protocol. The antisera to TV were evaluated by enzyme-linked im- antigens was determined in this study by ELISA using the MAbs MBr1 (Enzo Life Sciences, Inc., Farmingdale, NY) and HE-10 (Sigma-Aldrich, St. Louis, MO), respectively. To test saliva binding by TV, saliva samples at 1:1,000 were used to coat plates in PBS at 4°C overnight and then incubated with TV at 1 ϫ 10 4 PFU/ml. The bound TVs were detected by mouse anti-TV serum (1:3,500) and then by a goat antimouse IgG conjugated to horseradish peroxidase (HRP) (1:5,000). Color signals were developed with TMB (3,3=,4,4=-tetramethylbenzidine) and read at 450 nm.
Binding of TV with synthetic ABH tri-and tetrasaccharides. The synthetic ABH type 1 to 4 oligosaccharide-BSA conjugates in PBS were used to coat plates at 4°C overnight, which were blocked with 5% milk at room temperature for 1 h and then rinsed with 200 l of PBS. Next, 100 l (1 ϫ 10 3 PFU) of purified TV was added, and plates were incubated at 4°C overnight and rinsed with PBS three times. The bound TVs were detected by mouse anti-TV serum as described above.
Inhibition of TV replication by A type 3/4-and B-positive saliva and oligosaccharide conjugates in cell culture. Inhibition of TV replication was assessed by plaque reduction assay of TV in LLC-MK2 cells in 6-well plates. Type A saliva samples with different levels of the A type 3/4 antigen were tested for their ability to block TV replication, while type B saliva was used as a positive control. Saliva samples were boiled and clarified by centrifugation at 10,000 ϫ g for 10 min. The TV inoculum was incubated with saliva starting at a dilution of 1:300 in Dulbecco's modified Eagle medium (DMEM) with 6-fold serial dilutions. The tubes used were precoated with 5% BSA. After 1 h incubation at 37°C, the TV-saliva mixture was inoculated into LLC-MK2 cells and incubated at 37°C for 1.5 h. The plates were overlaid with 0.8% agarose. After a 2-day incubation, the plates were stained with crystal violet, and plaques were counted. The blocking rate (%) of the saliva was calculated by the reduction in plaque numbers in the wells treated with saliva relative to the number in untreated control wells. Blocking rate (expressed as a percentage) was calculated as follows: (1 Ϫ PFU of test well/PFU of control well) ϫ 100.
Procedures similar to those used for the plaque reduction assay were also used to determine the roles of the A type 3 and B oligosaccharide conjugates in blocking TV infection in cell cultures. Synthetic oligosaccharide (20 g/well) was preincubated with TV inoculum and then transferred to 6-well plates. The test tubes used for incubation of TVs with (Fig. 2A) . The TV binding signals correlated with neither the A antigens nor other HBGAs, except for the A type 3/4 antigens (r ϭ 0.85, P Ͻ 0.05) (Fig. 2B) Specificity of binding of TV to the A type 3 and B oligosaccharides. To further determine the binding targets of TV, we performed oligosaccharide-based binding assays using BSA-conjugated oligosaccharides representing four types (types 1 to 4) of the A, B, and H antigens). The results indicated that TV strongly bound all four types of the B antigen but only A type 3 among the four A type antigens (Fig. 3A) . The binding signals of TV to the A type 3 oligosaccharide were weaker than those to the B antigens (types 1 to 4). TV did not bind to the H antigens (Fig. 3A) , consistent with the lack of TV binding to any type O saliva (Fig. 2A) . The antigenic specificities of these oligosaccharides were also validated by corresponding MAbs (Fig. 3B) . The A type 3/4 MAb (HE-10) recognized the A type 3 and 4 but not the A type 1 or 2 antigens. This result indicates that MAb HE-10 recognizes an epitope of the A antigens differing from that recognized by TV, in which the former is shared by A types 3 and 4, while the latter is distinct between the two types. Similarly, the H type 3/4 MAb (MBrL) also recognized H type 4 antigens. Finally, MAb (BG2) bound all four types of the A antigens, indicating that a further distinct epitope on the A antigens is recognized by this MAb (Fig. 3A) .
RESULTS

Binding of TV to type
Roles of the A type 3/4 antigens in hemagglutination (HA) and HA inhibition (HAI) with TV. HA and HAI on TV were performed to further prove the specific interaction of TV with human HBGAs. TVs from different fractions of CsCl gradient centrifugation were analyzed by HA and HAI, revealing that the fractions (fractions 7 and 8) containing intact TVs hemagglutinated RBCs specifically (Fig. 4A) . In our initial study, V-shaped plates were used, which resulted in clear HA for type B RBCs but only marginal HA for the A type 3/4 RBCs (Fig. 4B) . To increase the sensitivity of the HA assay, flat-bottom plates were used, and the HA results were read under a microscope (Fig. 4E) . The involvement of the B antigens in TV HA was confirmed by blocking of the HA by type B saliva (Fig. 4B) , synthetic B type 1 to 4 oligosaccharides (Fig. 4C ) and anti-TV serum (Fig. 4D) . Both A type 3 and 4 BSA conjugates were also tested in the HAI assay, revealing blocking only by A type 3 BSA conjugate on A type 3/4 RBC HA of TV (Fig. 4E) . Interestingly, in the TV HA assay using A type 3/4-positive RBCs, competitive inhibition between the type B antigens and the A type 3/4 antigens occurred, in which the type B saliva completely blocked TV HA of A type 3/4 RBCs (Fig. 4B) . This result suggests that the TV most likely uses the same binding site for interaction with both the B and the A type 3 antigens. B HBGAs in TV replication, we performed a plaque reduction assay on TVs in cell culture using human saliva as a blocking reagent. Nearly complete inhibition (ϳ100%) of TV replication by the type B saliva at 1:300 was observed (Table 2) , while variable blocking results were obtained when the type A saliva samples were tested (data not shown). To determine the involvement of the A type 3 antigens in the blocking activities, saliva samples from two individuals with strong (OH45 and OH60) and two individuals with weak (OH32 and OH94) signals for A type 3/4 were tested. High inhibition of TV replication (Ͼ20 to 50%) was observed after TVs were incubated with saliva OH45 and OH60 (with strong A type 3/4 signals) at a dilution of 1:1,800. As expected, no blocking or weak blocking (Ͻ10%) was seen with saliva OH32 and OH94 (with weak A type 3/4 signals) even when a higher concentration of saliva (1:300) was used ( Table 2 ). All four saliva samples had similar levels of total type A antigens, indicating that the A type 3/4antigen in the saliva is responsible for the inhibition.
Synthetic type B-BSA conjugates reduce TV replication in cell culture. We first repeated the blocking experiments, described in a previous study, that showed that synthetic HBGA-BSA conjugates resulted in an increase in TV infection (13) . Using the same conditions, we observed an increase of plaque formation after incubation of TVs with the BSA-conjugated type A and B oligosaccharides compared with the control group without BSA conjugated oligosaccharides. However, it was noted that a similar increase was also seen when BSA alone without type A or B oligosaccharides was used (data not shown), indicating that such an increase of viral titers was nonspecific. After stepwise troubleshooting, we found that the observed "increase" in TV titers was due to nonspecific binding of TV to the incubation tubes, which could be prevented by BSA or the BSA conjugates. Because no additional proteins were included in the control groups, less TV can be removed from the tube to inoculate the cell cultures. As a result, all treatment groups showed more TV plaques after cultivation. This false result can be avoided by precoating of the tubes with BSA.
After resolving this problem, we repeated the oligosaccharideblocking assay and observed specific inhibition of TV replication by the type B-BSA conjugate, but the blocking efficiency was significantly lower than that of saliva (Table 3) . Although no blocking effects on TV replication by other oligosaccharide conjugates were observed, including B-PAA, A-BSA, A type 2-BSA, and A type 3-BSA conjugates, no increase in TV plaques occurred (Table  3) . We speculate that the lower blocking efficiency by the oligosaccharide conjugates could be due to their lower valence compared with the multivalent nature of the HBGAs of saliva. Collectively, our data support the notion that HBGAs play an important role in TV replication.
DISCUSSION
In this study, we verified that the TV recognizes all four types of the B antigens but only the A type 3 of the A antigens. The specificity of TV in recognizing the A type 3 antigens has been demonstrated by binding of TV with A type 3/4-positive saliva, detected with an anti-A type 3/4 MAb. We also obtained direct evidence of TV binding to the A type 3 and B antigens by oligosaccharidebased binding and blocking assays and by HA and HAI with A type 3/4-and B-positive human RBCs and saliva. The biological significance of HBGA as a host factor in TV replication has been demonstrated by specific blocking of TV replication in cell cultures using type B-specific HBGAs and saliva characterized as containing A type 3/4 antigens. Finally, our study clarified an unexplained result reported in the literature regarding the roles of human HBGAs in TV replication. Thus, we conclude that the recognition by TV of the A type 3 and B HBGAs is highly specific and biologically relevant.
The finding that TV recognizes both the A type 3 and B antigens further broadens our understanding of the nature of virushost interaction of caliciviruses with HBGAs. First, according to the cross-blocking results of TV between the A type 3 and B antigens, we predict that the TV may use a common receptor-binding interface to interact with both the A type 3 and B antigens. This is similar to what was observed in human NoVs that use a common HBGA binding interface to bind different ABH and Lewis antigens. Thus, we further predict that TV may rely on the shared ␤-galactose in the disaccharide precursors (core chains) and the fucose linked to the ␤-galactose in the A and B antigens (Fig. 1) as the major binding saccharide for TV to interact with HBGAs. However, since TV does not bind to any types of O saliva, the fucose that linked to the ␤-galactose of the secretor saliva may be dispensable for the interactions.
In this study, a MAb that recognizes A type 3/4 antigens was used for HBGA typing of human saliva, and a correlation of saliva binding by this MAb and by TV was observed, raising the question of whether the A type 4 antigen in human saliva is also involved in interaction with TV. According to the oligosaccharide-based binding assays, however, TV recognized A type 3 but not the other three types (1, 2, and 4) of the A antigens, indicating that the TV recognizes an epitope on the A antigens differ from that recognized by the MAb. The A antigens contain multiple sugar residues that may form different antigenic epitopes recognized by the MAb and TV, respectively. The recognition of distinct epitopes of human HBGAs in human milk has also been observed between human NoVs and HBGA-specific MAbs (25) . Thus, we conclude that TV recognizes the A type 3 antigens specifically, and the crossreactivity of the MAb to both A types 3 and 4 should not affect our conclusion. The finding that TV recognizes the A type 3 antigen also helped our understanding of the type specificity of HBGAs recognized by different human NoVs. For example, the prototype Norwalk virus (GI.1) recognizes mainly the type 1 chain of the A and H antigens, while the major epidemic GII.4 NoVs recognize mainly the type 3 chains of the A, B, and H antigens. This type specificity may have a role in clinical infection and prevalence of individual strains of NoVs in different human populations. Future studies to determine the distribution of individual types of the ABH and Lewis antigens in the general population and to explore their roles in the prevalence of individual genotypes of human NoVs are necessary.
The demonstration of the role of human HBGAs in TV replication by the cell culture-based blocking experiments described in our study is highly significant, because such a study is impossible to carry out with human NoVs due to the lack of a cell culture method and an animal model. Similar to results of a previous study (13) , significant reduction of TV replication in LLC-MK2 cells was seen after treatment of TVs with the A type 3 and B antigens. As an analogy, we predict that human HBGAs or a carbohydrate receptor also plays an important role in the replication of human NoVs and related caliciviruses (26) (27) (28) (29) . To look into the report of increased TV infectivity by type A and B oligosaccharides in an earlier study (13) , we carefully evaluated the experimental procedures described in the study and identified a potential problem that could cause a false result. We found that TV tends to bind to the test tubes in the preincubation step and that such nonspecific binding can be prevented by precoating of the tube with a protein solution, such as BSA. Our conclusion was strongly supported by a demonstration of an increase in TV titer by preincubation of TV with BSA and by avoiding such false results by precoating the test tubes with a BSA solution. The observed lower blocking efficacy of the oligosaccharide conjugates than human saliva could be due to a lower valence of the oligosaccharide conjugates than of saliva glycans.
